Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02705482
Title A Study to Evaluate MEDI0562 in Combination With Immune Therapeutic Agents in Adult Subjects With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors MedImmune LLC
Indications
Therapies
Age Groups: adult
Covered Countries USA | NLD | FRA

Facility Status City State Zip Country Details
Research Site Santa Monica California 90404 United States Details
Research Site Chicago Illinois 60611 United States Details
Research Site Saint Louis Missouri 63110 United States Details
Research Site Albuquerque New Mexico 87106 United States Details
Research Site New York New York 10032 United States Details
Research Site Huntersville North Carolina 28078 United States Details
Research Site Portland Oregon 97213 United States Details
Research Site Nashville Tennessee 37203 United States Details
Research Site Houston Texas 77030 United States Details
Research Site Villejuif 94805 France Details
Research Site Amsterdam 1066 CX Netherlands Details
Research Site Amsterdam 1081 HV Netherlands Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field